Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarantus Bioscience Holdings Inc (OTCQX US:AMBS)

2.17
Delayed Data
As of Sep 01
 +0.02 / +0.93%
Today’s Change
1.60
Today|||52-Week Range
19.80
-82.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization70.0K153.0K----
 
 
 
 
Operating ExpensesGross Income-70.0K-153.0K----
 
 
 
General Expenses5.6M21.2M----
 
 
 
Research And Development2.1M13.8M----
 
 
 
Total Operating Expenses5.7M21.4M----
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-21.4M----
 
 
 
Extraordinary Credit271.2K317.0K----
 
 
 
Extraordinary Charge-7.1M-5.4M----
 
 
 
Interest Expense On Debt2.6M813.0K----
 
 
 
Other Expenses0.00-50.0K----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M-27.3M----
 
 
 
Preferred Dividend-38.4K-875.0K----
 
 
 
Net Income-15.1M-27.3M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M4.9M----
 
 
 
Shares To Calculate EPS Diluted3.0M5.3M----
 
 
 
 
Earnings Per ShareEPS-$4.50-$6.00----
 
 
 
EPS Diluted-$4.50-$6.00----